APOC1 and hepatocellular carcinoma: Previous studies conducted on the serum of patients with fibrosis, cirrhosis, and hepatocellular carcinoma indicated that the mature, secreted form of apolipoprotein C-I lacking the 26-residue signal peptide is downregulated in these patients (77), concordant with the results reported here.